Last announcement was on 19 May 2004, which suggested a 2nd qtr 2004 data for the finalisation of the Hep E diagnostics licence agreement. The next announcement thereafter was supposed to be the completion of the Hep A diagnostic evaluation, early in the 3rd qtr.
See http://www.selectvaccines.com.au/downloads/Presentation%20to%20Annual%20General%20Meeting%2019%20May%2004.pdf
They did present at the Bio 2004 forum in San Fran early June, but I can't seem to find a copy of that presentation. (Don't expect it to reveal too much more)
Elimbah
(I hold SLT)
SLT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
